Responding to news of advance funding for community pharmacy during the COVID-19 pandemic, Chair of the RPS in England Professor Claire Anderson said:
“This is a welcome step in right direction for pharmacies facing immediate cash flow concerns but should come from new money. With rising costs, this will not yet be enough to support those pharmacy teams working hard on the frontline during the COVID-19 pandemic. As we await further details on the proposed medicines delivery service, must also see fair funding in the longer-term to help pharmacies keep their doors open to the public.
“Alongside this we are seeking further clarifications on how government protects all pharmacy teams, including pharmacists and support staff having appropriate access to PPE and timely testing for COVID-19 so they can continue looking after patients.
“In the face of growing pressures, we’d also look for an easing of the administrative burden, including stopping the management of prescription charges, as well as equal access to occupational health support for all staff.”